Literature DB >> 2196742

Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus.

Y Ueda1, S Morikawa, Y Matsuura.   

Abstract

The gene encoding the specific antigen (S antigen) induced on the surface of vaccinia virus-infected cells was mapped on the viral genome by the construction of recombinant viruses. The S gene is located in the 1.5-kbp XbaI-AccII fragment between 11.1 and 12.6 kbp from the right end of the viral genome. Nucleotide sequencing of the fragment revealed an open reading frame (ORF) of 351 codons capable of producing a polypeptide with a molecular weight (MW) of 40,701 Da. Mapping of the S mRNA by primer extension indicates the presence of the transcription initiation site that precedes the translation initiation codon by 14 nucleotides. The region preceding the S mRNA start site is extremely A/T-rich and has sequence similarity with other early genes. The signal for termination of transcription of the early genes, TTTTTAT, is included near the end of the ORF. The deduced amino acid sequence contains a typical membrane signal characterized by a hydrophobic region in the N-terminus. An early polypeptide with a MW of 40 kDa, in agreement with the size predicted from the ORF, was synthesized by cell-free translation of the mRNA selected by hybridization to a plasmid containing the region of the ORF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196742     DOI: 10.1016/0042-6822(90)90524-u

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.

Authors:  Shawn S Jackson; Petr Ilyinskii; Valérie Philippon; Linda Gritz; Alicia Gómez Yafal; Kimberly Zinnack; Kristin R Beaudry; Kelledy H Manson; Michelle A Lifton; Marcelo J Kuroda; Norman L Letvin; Gail P Mazzara; Dennis L Panicali
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

3.  The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.

Authors:  A Alcamí; J A Symons; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 4.  Functional organization of variola major and vaccinia virus genomes.

Authors:  S N Shchelkunov
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.

Authors:  Ren-Huan Xu; Daniel Rubio; Felicia Roscoe; Tracy E Krouse; Mary Ellen Truckenmiller; Christopher C Norbury; Paul N Hudson; Inger K Damon; Antonio Alcamí; Luis J Sigal
Journal:  PLoS Pathog       Date:  2012-01-05       Impact factor: 6.823

6.  A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding.

Authors:  Bruno Hernáez; Juan Manuel Alonso-Lobo; Imma Montanuy; Cornelius Fischer; Sascha Sauer; Luis Sigal; Noemí Sevilla; Antonio Alcamí
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

7.  A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

Authors:  C J McMahan; J L Slack; B Mosley; D Cosman; S D Lupton; L L Brunton; C E Grubin; J M Wignall; N A Jenkins; C I Brannan
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

8.  The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.

Authors:  Ren-Huan Xu; Matthew Cohen; Yong Tang; Eric Lazear; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen; Luis J Sigal
Journal:  J Exp Med       Date:  2008-04-07       Impact factor: 14.307

9.  Analysis of the monkeypox virus genome.

Authors:  S N Shchelkunov; A V Totmenin; P F Safronov; M V Mikheev; V V Gutorov; O I Ryazankina; N A Petrov; I V Babkin; E A Uvarova; L S Sandakhchiev; J R Sisler; J J Esposito; I K Damon; P B Jahrling; B Moss
Journal:  Virology       Date:  2002-06-05       Impact factor: 3.513

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.